EU clears Biotronik CRT-P for MRI usage

Biotronik has received European approval for the market release of its Evia HF-T pacemaker series, a cardiac resynchronization therapy-pacemaker (CRT-P) device approved for use in an MRI environment.

In addition, the Evia HF-T series offers remote patient management with Biotronik Home Monitoring, as well as data available via Biotronik's Heart Failure Monitor.

The usage of MR scans increases with age, due to an increased prevalence of comorbidities like stroke, brain tumors and arthritis. The prevalence of heart failure also increases with age. The average age of patients with heart failure is 75 years, making access to MR scanning an important advancement for heart failure patients, according to Berlin-based Biotronik.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup